Crystal structure of (1S*,2R*)-7-benzyloxy-2-methyl-3-tosyl-2,3,4,5-tetrahydro-1H-3-benzazepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists

MLA

Bernhard Wünsch, et al. “Crystal Structure of (1S*,2R*)-7-Benzyloxy-2-Methyl-3-Tosyl-2,3,4,5-Tetrahydro-1H-3-Benzazepin-1-Ol: Elucidation of the Relative Configuration of Potent Allosteric GluN2B Selective NMDA Receptor Antagonists.” Acta Crystallographica Section E: Crystallographic Communications, vol. 72, no. 5, May 2016, pp. 683–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....60b53e7a1ffc74d0d8d990bf03085952&authtype=sso&custid=ns315887.

APA

Bernhard Wünsch, Bastian Tewes, Bastian Frehland, & Roland Fröhlich. (2016). Crystal structure of (1S*,2R*)-7-benzyloxy-2-methyl-3-tosyl-2,3,4,5-tetrahydro-1H-3-benzazepin-1-ol: elucidation of the relative configuration of potent allosteric GluN2B selective NMDA receptor antagonists. Acta Crystallographica Section E: Crystallographic Communications, 72(5), 683–686.

Chicago

Bernhard Wünsch, Bastian Tewes, Bastian Frehland, and Roland Fröhlich. 2016. “Crystal Structure of (1S*,2R*)-7-Benzyloxy-2-Methyl-3-Tosyl-2,3,4,5-Tetrahydro-1H-3-Benzazepin-1-Ol: Elucidation of the Relative Configuration of Potent Allosteric GluN2B Selective NMDA Receptor Antagonists.” Acta Crystallographica Section E: Crystallographic Communications 72 (5): 683–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....60b53e7a1ffc74d0d8d990bf03085952&authtype=sso&custid=ns315887.